X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (22) 22
male (13) 13
mice (12) 12
female (11) 11
animals (10) 10
hematology (10) 10
cancer (9) 9
multiple myeloma (8) 8
oncology (8) 8
therapy (8) 8
aged (7) 7
middle aged (7) 7
adult (6) 6
analysis (6) 6
cell line, tumor (6) 6
expression (6) 6
imatinib mesylate (6) 6
apoptosis (5) 5
liver (5) 5
medicine & public health (5) 5
pathology (5) 5
surgery (5) 5
case report (4) 4
cell proliferation (4) 4
cells (4) 4
glycerol (4) 4
ii citrullinemia (4) 4
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4) 4
medical colleges (4) 4
mice, scid (4) 4
multiple myeloma - metabolism (4) 4
neoplasm transplantation (4) 4
activation (3) 3
aged, 80 and over (3) 3
amino acids (3) 3
amusements (3) 3
animal models (3) 3
antineoplastic agents - pharmacology (3) 3
apoptosis - drug effects (3) 3
aspartate (3) 3
benzamides (3) 3
biochemistry & molecular biology (3) 3
bisphosphonate (3) 3
carcinoma (3) 3
card, board, or roulette games (3) 3
chronic myelogenous leukemia (3) 3
chronic myeloid-leukemia (3) 3
citrulline (3) 3
drug synergism (3) 3
follow-up studies (3) 3
games (3) 3
games not otherwise provided for (3) 3
genetics & heredity (3) 3
glutamate (3) 3
glycerin (3) 3
glycerol 3-phosphate (3) 3
human necessities (3) 3
in-vivo (3) 3
indoor games using small moving playing bodies (3) 3
leukemia (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - pathology (3) 3
medicine, research & experimental (3) 3
metabolism (3) 3
metastasis (3) 3
mice, inbred balb c (3) 3
mice, inbred nod (3) 3
mice, nude (3) 3
mitochondria (3) 3
phosphates (3) 3
piperazines - therapeutic use (3) 3
prognosis (3) 3
proteins (3) 3
sodium pyruvate (3) 3
sports (3) 3
stem cells (3) 3
sucrose (3) 3
video games (3) 3
3rd-generation bisphosphonate (2) 2
abl gene mutation (2) 2
abl protein (2) 2
abridged index medicus (2) 2
acute lymphoblastic-leukemia (2) 2
alanine (2) 2
ammonia (2) 2
antineoplastic agents - therapeutic use (2) 2
arginine (2) 2
bcl-2 proteins (2) 2
bcr protein (2) 2
bcr-abl (2) 2
biophysics (2) 2
blast wave (2) 2
bone marrow (2) 2
breast carcinoma (2) 2
calculating (2) 2
carcinogenesis (2) 2
cell proliferation - drug effects (2) 2
cell-line (2) 2
chemistry, applied (2) 2
chemistry, physical (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2011, Volume 108, Issue 42, pp. 17468 - 17473
Bone marrow (BM) microenvironment (BMME) constitutes the sanctuary for leukemic cells. In this study, we investigated the molecular mechanisms for... 
Cell growth | K562 cells | Cell death | Leukemia | Cell lines | Coculture techniques | Mice | Chronic myeloid leukemia | Drug resistance | Apoptosis | Minimal residual disease | Bone marrow niche | Chemoresistance | Philadelphia-positive leukemia | APOPTOSIS | MULTIDISCIPLINARY SCIENCES | BCR-ABL | CHRONIC MYELOID-LEUKEMIA | OVEREXPRESSION PROTECTS | chemoresistance | THERAPY | bone marrow niche | minimal residual disease | CANCER PROGRESSION | LYMPHOBLASTIC-LEUKEMIA | IMATINIB MESYLATE | CELL-LINE | Neoplasm Transplantation | Cell Proliferation | Signal Transduction | Humans | Galectin 3 - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Transplantation, Heterologous | Tumor Microenvironment - physiology | Mice, SCID | Culture Media, Conditioned | Drug Resistance, Neoplasm - genetics | Animals | Tumor Microenvironment - genetics | Models, Biological | Bone Marrow - pathology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice, Inbred NOD | Drug Resistance, Neoplasm - physiology | Research | Diagnosis | Drug therapy | Risk factors | Proteins | Bone marrow | Signal transduction | Gene expression | Index Medicus | BCR protein | Cell proliferation | Animal models | Multidrug resistance | Genotoxicity | Extracellular signal-regulated kinase | Stroma | AKT protein | Abl protein | Mcl-1 protein | Molecular modelling | Microenvironments | Fusion protein | Protein-tyrosine kinase | galectin-3 | Cell migration | Biological Sciences
Journal Article
Molecular Therapy, ISSN 1525-0016, 07/2019, Volume 27, Issue 7, pp. 1242 - 1251
Journal Article
Journal Article
Pediatric, Allergy, Immunology, and Pulmonology, ISSN 2151-321X, 12/2018, Volume 31, Issue 4, pp. 215 - 220
Background: The modified pulmonary index score (mPIS) is reported to be useful for assessing bronchial asthma severity. However, mPIS has not been compared... 
inhalation therapy | pulmonary index score | bronchial asthma | childhood asthma | isoproterenol | SCORE | THERAPY | ALLERGY | RESPIRATORY SYSTEM | PULMONARY INDEX | PEDIATRICS | IMMUNOLOGY | Respiratory therapy | Corticoids | Therapy | Wood | Correlation analysis | Lung | Children | Isoproterenol | Respiration | Asthma | Inhalation
Journal Article
Applied Physics Express, ISSN 1882-0778, 05/2015, Volume 8, Issue 5, p. 51603
The origin of gate-bias stress effect in organic field-effect transistors of poly(9,9-dioctylfluorene-co-bithiophene) has been studied by the direct... 
PHYSICS, APPLIED | STABILITY | FIELD-EFFECT TRANSISTORS
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2008, Volume 140, Issue 2, pp. 181 - 190
Summary The effect of ABT-737, a BH3-mimicking inhibitor for anti-apoptotic Bcl-2 and Bcl-XL, but not Mcl-1, against Bcr-Abl-positive (Bcr-Abl+) leukaemic... 
ABT-737 | Bcr-Abl | homoharringtonine | imatinib | chronic myeloid leukaemia | Chronic myeloid leukaemia | Imatinib | Homoharringtonine | CHRONIC MYELOGENOUS LEUKEMIA | APOPTOSIS | DOMAIN MUTATIONS | BH3 MIMETIC ABT-737 | THERAPY | TYROSINE KINASE INHIBITOR | BCL-2 PROTEINS | HEMATOLOGY | EXPRESSION | IMATINIB MESYLATE | CELL-LINE | Neoplasm Transplantation | Apoptosis - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Drug Resistance, Neoplasm | Male | Transplantation, Heterologous | Antineoplastic Agents - therapeutic use | Biphenyl Compounds - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Nitrophenols - therapeutic use | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Drug Evaluation, Preclinical | Piperazines - therapeutic use | Mice, SCID | Sulfonamides - pharmacology | Piperazines - pharmacology | Animals | Sulfonamides - therapeutic use | Harringtonines - pharmacology | Survival Analysis | Mice, Inbred NOD | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Mice | Antineoplastic Agents, Phytogenic - pharmacology | Chemotherapy | Drug resistance | Tissue specific antigens | Cancer | Index Medicus
Journal Article
Explosion, ISSN 0916-801X, 2015, Volume 25, Issue 3, pp. 144 - 149
Journal Article
International Journal of Hematology, ISSN 0925-5710, 6/2008, Volume 87, Issue 5, pp. 507 - 515
Journal Article
Molecular Genetics and Metabolism, ISSN 1096-7192, 04/2017, Volume 120, Issue 4, pp. 306 - 316
Journal Article
Blood, ISSN 0006-4971, 01/2007, Volume 109, Issue 1, pp. 306 - 314
Central nervous system (CNS) relapse accompanying the prolonged administration of imatinib mesylate has recently become apparent as an impediment to the... 
CHRONIC MYELOGENOUS LEUKEMIA | P-GLYCOPROTEIN INHIBITORS | PHILADELPHIA-CHROMOSOME | ACUTE LYMPHOBLASTIC-LEUKEMIA | ABL GENE MUTATION | MULTIDRUG-RESISTANCE | CEREBROSPINAL-FLUID | HEMATOLOGY | LYMPHOID BLAST CRISIS | IMATINIB MESYLATE | CHRONIC MYELOID-LEUKEMIA | Neoplasm Transplantation | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Cyclosporine - pharmacology | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | K562 Cells - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Antineoplastic Agents - pharmacology | K562 Cells - transplantation | Pyrimidines - administration & dosage | src-Family Kinases - antagonists & inhibitors | Piperazines - therapeutic use | Pyrimidines - pharmacology | Random Allocation | Mice, SCID | Imatinib Mesylate | Piperazines - pharmacology | Drug Synergism | Cyclosporine - therapeutic use | Protein Kinase Inhibitors - administration & dosage | Injections | Animals | Mice, Nude | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Cyclosporine - administration & dosage | Fusion Proteins, bcr-abl - antagonists & inhibitors | Brain - pathology | Mice, Inbred NOD | Mice | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | Benzamides | Drug Resistance, Neoplasm - drug effects | Drug Screening Assays, Antitumor | Index Medicus | Abridged Index Medicus
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 03/2007, Volume 354, Issue 2, pp. 613 - 618
We evaluated the mechanism of recognition of myeloma cells by γδT cells. The expanded γδT cells killed RPMI8226 and U266 myeloma cells in a γδT-cell... 
Bisphosphonate | ICAM-1 | γδT cells | Immunotherapy | Multiple myeloma
Journal Article